1. Home
  2. ALT vs TSAT Comparison

ALT vs TSAT Comparison

Compare ALT & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • TSAT
  • Stock Information
  • Founded
  • ALT 1997
  • TSAT 1969
  • Country
  • ALT United States
  • TSAT Canada
  • Employees
  • ALT 59
  • TSAT N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • TSAT Metal Fabrications
  • Sector
  • ALT Health Care
  • TSAT Industrials
  • Exchange
  • ALT Nasdaq
  • TSAT Nasdaq
  • Market Cap
  • ALT 501.9M
  • TSAT 515.2M
  • IPO Year
  • ALT N/A
  • TSAT 1996
  • Fundamental
  • Price
  • ALT $4.86
  • TSAT $24.65
  • Analyst Decision
  • ALT Strong Buy
  • TSAT
  • Analyst Count
  • ALT 7
  • TSAT 0
  • Target Price
  • ALT $16.33
  • TSAT N/A
  • AVG Volume (30 Days)
  • ALT 3.2M
  • TSAT 101.1K
  • Earning Date
  • ALT 11-06-2025
  • TSAT 11-04-2025
  • Dividend Yield
  • ALT N/A
  • TSAT N/A
  • EPS Growth
  • ALT N/A
  • TSAT N/A
  • EPS
  • ALT N/A
  • TSAT N/A
  • Revenue
  • ALT $20,000.00
  • TSAT $324,440,552.00
  • Revenue This Year
  • ALT N/A
  • TSAT N/A
  • Revenue Next Year
  • ALT N/A
  • TSAT N/A
  • P/E Ratio
  • ALT N/A
  • TSAT N/A
  • Revenue Growth
  • ALT N/A
  • TSAT N/A
  • 52 Week Low
  • ALT $2.90
  • TSAT $11.04
  • 52 Week High
  • ALT $10.88
  • TSAT $36.85
  • Technical
  • Relative Strength Index (RSI)
  • ALT 68.61
  • TSAT 37.30
  • Support Level
  • ALT $4.40
  • TSAT $23.10
  • Resistance Level
  • ALT $4.75
  • TSAT $26.00
  • Average True Range (ATR)
  • ALT 0.29
  • TSAT 1.81
  • MACD
  • ALT 0.07
  • TSAT -0.35
  • Stochastic Oscillator
  • ALT 95.22
  • TSAT 16.08

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About TSAT Telesat Corporation

Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.

Share on Social Networks: